Published in J Biomed Mater Res on July 01, 1996
A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med (1995) 6.14
Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol (1997) 5.94
Autoimmune murine thyroiditis relation to histocompatibility (H-2) type. Science (1971) 3.31
Clinicopathologic description of myocarditis. J Am Coll Cardiol (1991) 3.20
Avocado soybean unsaponifiables (ASU) suppress TNF-alpha, IL-1beta, COX-2, iNOS gene expression, and prostaglandin E2 and nitric oxide production in articular chondrocytes and monocyte/macrophages. Osteoarthritis Cartilage (2007) 3.04
Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med (2000) 3.00
Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol (1987) 2.65
Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest (2000) 2.35
Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis. J Immunol (1987) 2.28
Hypothesis: the aging paradox and autoimmune disease. Autoimmunity (1991) 2.09
Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: a serine proteinase effect. Thorax (1984) 2.07
Spatial and temporal operation of the Scotia Sea ecosystem: a review of large-scale links in a krill centred food web. Philos Trans R Soc Lond B Biol Sci (2007) 1.95
Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. J Immunol (1986) 1.86
Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis. Thorax (1984) 1.82
Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience (1991) 1.78
In vitro lymphocyte transformation in atopic patients: induced by antigens. J Allergy (1967) 1.78
Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions. J Immunol (1971) 1.76
Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J Exp Med (1977) 1.73
Cellular basis of the genetic control of immune responsiveness to murine thyroglobulin in mice. Cell Immunol (1975) 1.72
Transfer of experimental autoimmune thyroiditis of the mouse by serum. J Immunol (1971) 1.71
High-resolution computed tomography scanning in alpha1-antitrypsin deficiency: relationship to lung function and health status. Eur Respir J (2001) 1.71
Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J (2001) 1.67
Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax (2000) 1.65
Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract. Antimicrob Agents Chemother (1998) 1.62
From infection to autoimmunity. J Autoimmun (2001) 1.59
Studies on experimental thyroiditis. Ann N Y Acad Sci (1965) 1.57
Iodine-induced autoimmune thyroiditis in NOD-H-2h4 mice. Clin Immunol Immunopathol (1996) 1.57
Use of mortality within 30 days of a COPD hospitalisation as a measure of COPD care in UK hospitals. Thorax (2013) 1.55
Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax (2005) 1.55
Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis. J Exp Med (1985) 1.55
Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am J Pathol (2001) 1.52
Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans. Cancer (1995) 1.51
Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J (2000) 1.50
Rebreathing during use of the Air-Viva resuscitation bag: a hazard. Br Med J (Clin Res Ed) (1983) 1.50
Assessment of airway neutrophils by sputum colour: correlation with airways inflammation. Thorax (2001) 1.48
Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med (1999) 1.45
Interleukin 1 or tumor necrosis factor can promote Coxsackie B3-induced myocarditis in resistant B10.A mice. J Exp Med (1992) 1.45
Chitosan supports the expression of extracellular matrix proteins in human osteoblasts and chondrocytes. J Biomed Mater Res (2000) 1.43
Heparin, deep venous thrombosis, and trauma patients. Am J Surg (1991) 1.42
Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation (2001) 1.40
Heart-specific autoantibodies induced by Coxsackievirus B3: identification of heart autoantigens. Clin Immunol Immunopathol (1987) 1.40
T-cell regulation in autoimmune thyroiditis. Immunol Rev (1981) 1.40
Coxsackievirus B3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains. J Am Coll Cardiol (1987) 1.39
The silicone breast implant controversy: the other courtroom. Arthritis Rheum (1996) 1.38
Nitric oxide inhibits viral replication in murine myocarditis. J Clin Invest (1996) 1.36
Autoimmune murine thyroiditis. IV. Localization of genetic control of the immune response. J Immunol (1974) 1.34
Regulation of autoimmune response to mouse thyroglobulin: influence of H-2D-end genes. J Immunol (1979) 1.34
Immune response to Haemophilus parainfluenzae in patients with chronic obstructive lung disease. Clin Diagn Lab Immunol (2000) 1.33
Syngeneic thyroglobulin is immunogenic in good responder mice. Eur J Immunol (1981) 1.31
Role of IL-1 and tumor necrosis factor in coxsackie virus-induced autoimmune myocarditis. J Immunol (1993) 1.30
Experimental autoimmune thyroiditis. In vitro cytotoxic effects of T lymphocytes on thyroid monolayers. J Exp Med (1983) 1.30
Contribution of the innate immune system to autoimmune myocarditis: a role for complement. Nat Immunol (2001) 1.30
The presence of thyroid autoantibodies in children and adolescents with autoimmune thyroid disease and in their siblings and parents. Clin Immunol Immunopathol (1982) 1.29
The pathogenesis of postinfectious myocarditis. Clin Immunol Immunopathol (1996) 1.28
Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD. Thorax (2001) 1.27
In vitro susceptibility of Neisseria gonorrhoeae to spectinomycin examined by a broth dilution method. Antimicrob Agents Chemother (1973) 1.25
Cytotoxicity of human thyroid autoantibodies. Ann N Y Acad Sci (1965) 1.24
Experimental thyroiditis in the rhesus monkey. I. Cytotoxic, mixed-agglutinating and complement-fixing antibodies. Clin Exp Immunol (1966) 1.23
Neonatal thymectomy increases spontaneous autoimmune thyroiditis. J Immunol (1973) 1.23
Sputum sol-phase proteins and elastase activity in patients with cystic fibrosis. Eur J Respir Dis (1984) 1.22
Tolerance to thyroglobulin by activating suppressor mechanisms. Ann N Y Acad Sci (1982) 1.22
Multicenter experience with perventricular device closure of muscular ventricular septal defects. Pediatr Cardiol (2005) 1.21
Autoimmune myocarditis: a paradigm of post-infection autoimmune disease. Immunol Today (1988) 1.21
Neonatal thymectomy increases the incidence of spontaneous and methylcholanthrene-enhanced thyroiditis in rats. Science (1974) 1.21
Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res (2000) 1.20
Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am J Cardiol (1999) 1.20
Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax (2003) 1.20
Airways inflammation in chronic bronchitis: the effects of smoking and alpha1-antitrypsin deficiency. Eur Respir J (2000) 1.19
Splitting of human thyroglobulin. I. Reduction and alkylation. Clin Exp Immunol (1969) 1.19
Short term response of patients with bronchiectasis to treatment with amoxycillin given in standard or high doses orally or by inhalation. Thorax (1986) 1.19
Experimental thyroiditis in the rhesus monkey. 3. Course of the disease. Clin Exp Immunol (1966) 1.18
Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet (1987) 1.15
Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol (1990) 1.14
Postinfectious autoimmunity: two distinct phases of coxsackievirus B3-induced myocarditis. Ann N Y Acad Sci (1986) 1.14
Simple method for quantifying viable bacterial numbers in sputum. J Clin Pathol (1995) 1.13
Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid. Proc Natl Acad Sci U S A (2000) 1.13
Effect of antibiotic treatment on sputum elastase in bronchiectatic outpatients in a stable clinical state. Thorax (1984) 1.13
Resuscitation training for medical students in the United Kingdom--a comparison with the United States of America. Intensive Care Med (1987) 1.12
Mouse thyroid primary culture. Biochem Biophys Res Commun (1999) 1.12
Regulation of experimental autoimmune thyroiditis: mapping of susceptibility to the I-A subregion of the mouse H-2. Immunogenetics (1982) 1.12
Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis. J Am Coll Cardiol (1990) 1.11
Inflammatory heart disease: a role for cytokines. Lupus (2005) 1.11
Coxsackievirus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus. Clin Exp Immunol (1987) 1.11
Viral damage or 'molecular mimicry'-placing the blame in myocarditis. Nat Med (2000) 1.11
Serum antibodies to outer membrane proteins (OMPs) of Moraxella (Branhamella) catarrhalis in patients with bronchiectasis: identification of OMP B1 as an important antigen. Infect Immun (1995) 1.11
Antigens of mammalian cell cultures. I. Species-specific antigens. Lab Invest (1967) 1.10
Thyroid antibodies in spontaneous autoimmune thyroiditis in the Buffalo rat. J Immunol (1976) 1.10
Dynamics of respiratory tract colonization by Branhamella catarrhalis in bronchiectasis. Am J Respir Crit Care Med (1995) 1.09
Autoimmune murine thyroiditis. VIII. Role of different thyroid antigens in the induction of experimental autoimmune thyroiditis. Immunology (1976) 1.08
Fluorescent antibody technic used for identification and typing of Streptococcus pneumoniae. Am J Clin Pathol (1982) 1.08
Induction of multiple heart autoantibodies in mice with coxsackievirus B3- and cardiac myosin-induced autoimmune myocarditis. J Immunol (1994) 1.06
The chemotactic activity of sputum from patients with bronchiectasis. Am J Respir Crit Care Med (1998) 1.06
Iodination of human thyroglobulin (Tg) alters its immunoreactivity. I. Iodination alters multiple epitopes of human Tg. Clin Exp Immunol (1998) 1.06
A teenager with pacemaker twiddler syndrome. J Pediatr (1997) 1.05
Autoantigenic determinants on human thyroglobulin. II. Determinants recognized by autoantibodies from patients with chronic autoimmune thyroiditis compared to autoantibodies from healthy subjects. Clin Immunol Immunopathol (1990) 1.05
Experimental thyroiditis in the rhesus monkey. II. Precipitating, haemagglutinating and anaphylactogenic antibodies. Clin Exp Immunol (1966) 1.05
Exercise capacity predicts health status in alpha(1)-antitrypsin deficiency. Am J Respir Crit Care Med (2001) 1.05
MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. Eur Respir J (2000) 1.04